Quinoxaline, 5-(bromomethyl)-, 95%, 100mg

Azepane-4-carbonitrile, 95+%, 10g

(3-Methoxy-4-(trifluoromethoxy)phenyl)boronic acid, 95%, 250mg

2-Chlorobenzoic acid , >=98 %, for synthesis, 2.5 kg, plastic packaging.

CEFAZEDONE, 95%, 25g

(S)-2-(N-Fmoc-N-methyl-amino)-3-cyclopropylpropanoic acid, 98%, 500mg

Methyl 4-borono-3-chlorobenzoate, 95.0%, 5g

N-(3-Aminopropyl)diethanolamine>90.0%(GC)500g

(S)-2-Aminobut-3-enoic acid hydrochloride, 95.0%, 1g

tert-Butyl 4,6-dibromoindoline-1-carboxylate, 98%, 250mg

Fumaraldehyde Bis(dimethyl Acetal)>90.0%(GC)5g

2-(Trifluoromethoxy)phenylboronic Acid (contains varying amounts of Anhydride)5g

Methyl 2-chloro-4-methylbenzoate, 25g